Physical trauma, surgery, infection or psychological stress may trigger symptoms. People who have psoriasis, a skin disease ...

For patients with psoriatic arthritis, switching directly from adalimumab to tofacitinib with no washout period presents no ...

Arthritis is a common condition characterized by joint pain and stiffness. It’s crucial to debunk myths about its causes, age ...

The day that I had my first real psoriatic arthritis flare, I was getting up to go to work. I couldn't grip my pants well enough to pull them up. I couldn't get dressed. I couldn't move enough to ...

Arthritis is often treated as a singular condition. Yet, as noted above, it’s an umbrella term for scores of disorders ...

Learn about rheumatoid vasculitis, neutrophilic dermatoses, and other rheumatoid arthritis rashes, their symptoms, and when ...

Direct-to-consumer drug ads are prohibited in almost all countries besides the US. By leading doctors to prescribe unnecessary and more expensive treatments at the request of their patients, they also ...

The phase 3 POETYK PsA-1 trial evaluated the drug in patients who were not previously treated with a biologic ...

Regulatory ApprovalFormycon and Fresenius Kabi announce MHRA approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara® 15.01.2025 / 06:30 CET/CESTThe issuer is solely responsible for the ...

Formycon and Fresenius Kabi announce MHRA approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara® Otulfi ® received MHRA approval for both subcutaneous and intravenous formulations, to ...